Torys is home to a particularly impressive IP litigation team, that has vast trial, appellate and judicial review litigation experience. The practice spans an array of industries, including industrials, mining and telecoms in addition to biotech and pharmaceuticals. Spearheading the group, Andrew Shaughnessy frequently assists in patent and trademark infringement cases. Andrew Bernstein is active in matters involving the life sciences, information technology and media industries, whilst Yael Bienenstock has broad experience extending to patent litigation and data protection. Nicole Mantini has notable specialism in the pharmaceutical and biotechnology sectors. All lawyers mentioned work in Toronto.
Legal 500 Editorial commentary
Key clients
- LiquidPower Specialty Products Inc. (“LSPI”)
- Amgen Inc.
Work highlights
Acting as counsel for LSPI in a patent impeachment action and patent infringement action concerning the patent for a drag reduction additive.
Representing Amgen in proceedings before the Federal Court of Canada under PM(NOC) Regulations concerning the patents for KYPROLIS (carfilzomib), in four separate proceedings in connection with the KYPROLIS patent.
Representing Amgen in proceedings before the Federal Court of Canada under PM(NOC) Regulations concerning the patents for Amgen’s Ustekinumab biosimilar WEZLANA.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Andrew Shaughnessy
Other key lawyers
Andrew Bernstein; Yael Bienenstock; Nicole Mantini